Could The Joint Corp. (JYNT) See a Reversal After Breaking Its 52-Week High?

June 14, 2018 - By James Guidry

The Joint Corp. (NASDAQ:JYNT) Logo

The stock of The Joint Corp. (NASDAQ:JYNT) hit a new 52-week high and has $8.79 target or 8.00 % above today’s $8.14 share price. The 9 months bullish chart indicates low risk for the $110.59 million company. The 1-year high was reported on Jun, 14 by Barchart.com. If the $8.79 price target is reached, the company will be worth $8.85 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 3.24% or $0.255 during the last trading session, reaching $8.135. About 97,473 shares traded or 14.12% up from the average. The Joint Corp. (NASDAQ:JYNT) has risen 80.25% since June 14, 2017 and is uptrending. It has outperformed by 67.68% the S&P500.

The Joint Corp. (NASDAQ:JYNT) Ratings Coverage

Among 2 analysts covering Joint (NASDAQ:JYNT), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Joint had 2 analyst reports since March 28, 2018 according to SRatingsIntel. The stock of The Joint Corp. (NASDAQ:JYNT) earned “Buy” rating by Roth Capital on Thursday, June 7.

The Joint Corp. develops, owns, operates, franchises, supports, and manages chiropractic clinics in the United States. The company has market cap of $110.59 million. As of June 30, 2017, it had 47 company-operated or managed clinics and 336 franchisee operated clinics. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.